Regulatory polymorphisms in key candidate genes for disease susceptibility and drug response: a mandate for valid genetic biomarkers

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

Wolfgang Sadee is Professor of the Ohio State University. He is also Chief Scientific Officer of AIKO Biotechnology, Inc. He consults for pharmaceutical companies, but declares no external conflict of interest with respect to the content of this article. Several genetic variants mentioned in this article are included with current patent applications pursued by the Ohio State University. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.